Stock 688617 APT MEDICAL INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings APT Medical Inc.

Equities

688617

CNE100004C45

End-of-day quote Shanghai S.E.
Other stock markets
 18:00:00 2024-04-29 EDT 		5-day change 1st Jan Change
503.7 CNY +4.58% Intraday chart for APT Medical Inc. +6.28% +29.65%
04-29 APT Medical Inc. Announces Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders. CI
04-25 APT Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • The company's profit outlook over the next few years is a strong asset.
  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses

  • With an expected P/E ratio at 51.19 and 37.42 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • In relation to the value of its tangible assets, the company's valuation appears relatively high.
  • The company is not the most generous with respect to shareholders' compensation.
  • Over the past twelve months, analysts' opinions have been revised negatively.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
APT MEDICAL INC. Stock APT Medical Inc.
+29.65% 4.63B -
SHOCKWAVE MEDICAL, INC. Stock Shockwave Medical, Inc.
+73.37% 12.38B
B-
PENUMBRA, INC. Stock Penumbra, Inc.
-17.09% 7.99B
C+
MASIMO CORPORATION Stock Masimo Corporation
+16.88% 7.21B
C-
GETINGE AB Stock Getinge AB
+3.57% 5.79B
B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. Stock Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
+11.77% 5.35B
D+
ASAHI INTECC CO., LTD. Stock Asahi Intecc Co., Ltd.
-17.74% 4.17B
B-
INARI MEDICAL, INC. Stock Inari Medical, Inc.
-35.26% 2.44B
C
SKAN GROUP AG Stock SKAN Group AG
+3.09% 2.03B -
SHENZHEN YHLO BIOTECH CO., LTD. Stock Shenzhen YHLO Biotech Co., Ltd.
+4.85% 1.88B -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 688617 Stock
  4. Ratings APT Medical Inc.